Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
  Top » Catalog » Books » My Account  |  Cart Contents  |  Checkout   
Quick Find
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Doxycycline: Medical Uses and Effects
Shopping Cart more
0 items
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Liver Cancer: New Research (Horizons in Cancer Research, Volume 11)
Tell A Friend
Tell someone you know about this product.
Liver Cancer: New Research (Horizons in Cancer Research, Volume 11)
Retail Price: $195.00
10% Online Discount
You Pay:

Editors: Lee, Felix
Book Description:
Primary liver cancer occurs when cancerous (malignant) cells begin to grow in the tissues of liver. Although many cancers are on the decline, the incidence of primary liver cancer in the United States increased more than 70 percent between 1975 and 1995. The increase is linked to rising rates of hepatitis B and C infection - the leading causes of liver cancer. Far more common than primary liver cancer, however, is cancer that occurs when tumors from other parts of the body spread (metastasize) to the liver. The liver is especially vulnerable to invasion by tumor cells and with the exception of the lymph nodes, is the most common site of metastasis. There are two main kinds of liver cancer. Heptoma and cholangiocarcinoma. Heptoma is cancer of the hepatocytes. (The main functioning liver cell). Hepatoma is primary liver cancer. Hepatoma usually grows in the liver as a ball-like tumor, invading the normal tissue surrounding it. Cancer of the bile duct cells is called cholangiocarcinoma. Cholangiocarcinoma originates in the bile ducts and is often caused by infestation with the liver fluke Clonorchis (a parasite). The cancer grows along the bile ducts in sheets or lines, and is difficult to find on X-ray studies. This book presents the latest new research developments from around the world in the field of liver cancer.

Table of Contents:

Chapter 1. Malignant Epithelial Liver Tumors in Children, Adolescents, and Adults: Molecular Pathways of Cancerogenesis, Growth, and Spread, pp.1-41;
(Arthur Zimmermann, Institute of the University, Berne, Switzerland);

Chapter 2. Tumor Biology of Colorectal Liver Metastases, pp. 43-57;
(Curtis J. Wray and Syed A. Ahmad, University of Cincinnati College of Medicine; Russell S. Berman, New York University School of Medicine);

Chapter 3. Colorectal Cancer Liver Metastases: Destruction or Resection?, pp.59-78;
(Salvatore Gruttadauria, University of Pittsburgh Medical Center European Medical Division; and Zakiyah Kadry, Thomas E Starzl Transplantation Institute, University of Pittsburgh Medical Center);

Chapter 4. Strategies for Inferior Phrenic Arteriography and Transcatheter Arterial Chemoembolization in Patients with Hepatocellular Carcinoma, pp.79-99;
(Kwang-Hun Lee, Yong Dong Severance Hospital, Republic of Korea);

Chapter 5. MDM-2 Over-Expression in Hepatitis B x Antigen Positive Hepatocellular Carcinoma, pp.101-117;
(Jie Liu, Helena M.G.P.V. Reis, Zhaorui Lian, Jingbo Pan, Li Li,and Mark A. Feitelson, Thomas Jefferson University, Philadelphia; Minghua Zhu, Meng-Chao Wu, and Hong-Yang Wang, Second Military Medical College, P. R. China; Patrick Arbuthnot and Michael C. Kew, University of the Witwatersrand, Johannesburg, South Africa);

Chapter 6. Understanding Mechanisms of Hepatocarcinogenicity of the Breast Cancer Drug Tamoxifen at the Molecular Level: Relative Risks to Women versus Rodents, pp. 119-159;
(Ian N.H. White and Karen Brown, University of Leicester, UK);

Chapter 7. Immunotherapy in Metastic Liver Disease, pp.161-184;
(Jannis Kountouras, Christos Zavos, and Dmitrios Chatzopoulos, Aristotle University of Thessaloniki, Greece);

Chapter 8. Cancer Surveillance Following Orthotopic Liver Transplantation, pp.185-201;
(James F. Trotter, University of Colorado Health Sciences Center, Denver);

Chapter 9. Angiogenesis Related Factore in Hepatocellular Carcinoma and Anti-Angiogenesis Therapy, pp.203-226;
(Baomin Shi, Hongjun Sun, and Xiuyan Wang, Clinical College of Shandong University, China; Zhen Yang, Huazhong University of Science and Technology, China);

Chapter 10. Research on Angigenesis in Liver Cancer and Its Clinical Implications, pp.227-251;
(Ronnie Tung-Ping Poon, The University of Hong Kong);


      Horizons in Cancer Research
   Binding: Hardcover
   Pub. Date: 2006
   ISBN: 1-59454-182-5
   Status: AV
Status Code Description
AN Announcing
FM Formatting
PP Page Proofs
FP Final Production
EP Editorial Production
PR At Prepress
AP At Press
AV Available
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2021

Liver Cancer: New Research (Horizons in Cancer Research, Volume 11)